Zenas BioPharma, Inc.'s market cap is currently $1.03B. The company's EPS TTM is $-3.899; its P/E ratio is ―; Zenas BioPharma, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Currency in USD
Zenas BioPharma, Inc. Earnings and Revenue History
